Executive Vice President and Chief Financial Officer
CEDAR FAIR L P
Effective
2024-07-01
Filed
July 1, 2024, 7:59 PM ET
Additionally, on the Closing Date and as a result of the Mergers, each of Richard A. Zimmerman (President and Chief Executive Officer), Tim Fisher (Chief Operating Officer), Brian C. Witherow (Executive Vice President and Chief Financial Officer), Brian Nurse (Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary), David R. Hoffman (Senior Vice President and Chief Accounting Officer) and Monica Sauls (Senior Vice President and Chief Human Resources Officer) ceased to serve as officers of the General Partner.
Departed
Richard A. Zimmerman
President and Chief Executive Officer
CEDAR FAIR L P
Effective
2024-07-01
Filed
July 1, 2024, 7:59 PM ET
Additionally, on the Closing Date and as a result of the Mergers, each of Richard A. Zimmerman (President and Chief Executive Officer), Tim Fisher (Chief Operating Officer), Brian C. Witherow (Executive Vice President and Chief Financial Officer), Brian Nurse (Executive Vice President, Chief Legal and Compliance Officer and Corporate Secretary), David R. Hoffman (Senior Vice President and Chief Accounting Officer) and Monica Sauls (Senior Vice President and Chief Human Resources Officer) ceased to serve as officers of the General Partner.
Appointed
Frederick A. Cromer
Executive Vice President and Chief Financial Officer
On June 25, 2024, Versus Systems, Inc. (the “Company”) Chief Executive Officer and Director Matthew Pierce, Chair of the Board Keyvan Peymani, Chief Financial Officer Craig Finster, and independent directors Michelle Gahagan and Shannon Pruitt tendered their resignations from the Company, effective immediately.
On June 25, 2024, Versus Systems, Inc. (the “Company”) Chief Executive Officer and Director Matthew Pierce, Chair of the Board Keyvan Peymani, Chief Financial Officer Craig Finster, and independent directors Michelle Gahagan and Shannon Pruitt tendered their resignations from the Company, effective immediately.
Appointed
Curtis Wolfe
Chief Executive Officer and Chief Financial Officer
J. Ted Nissen will become Chief Executive Officer of the Bank
Departed
Bo Kruse
Chief Financial Officer and Treasurer
Y-mAbs Therapeutics, Inc.
Effective
2024-07-31
Successor
Peter Pfreundschuh
Filed
July 1, 2024, 7:59 PM ET
succeeded Bo Kruse, who is expected to remain available to the Company for a period of time following the conclusion of his employment on July 31, 2024, during which time Mr. Kruse will assist in the transition of his responsibilities and duties.
Appointed
Peter Pfreundschuh
Chief Financial Officer and Treasurer
Y-mAbs Therapeutics, Inc.
Effective
2024-06-28
Filed
July 1, 2024, 7:59 PM ET
On June 27, 2024, the Board of Directors (the “Board”) of Y-mAbs Therapeutics, Inc. (the “Company”) appointed Peter Pfreundschuh to serve as the Company’s Chief Financial Officer and Treasurer, effective June 28, 2024 (the “Effective Date”).
On July 1, 2024, Tim Sheehy, President, Chief Executive Officer, and director of the Company, notified the Company of his decision to resign from his position as President, Chief Executive Officer, and from the Board, effective immediately.
Appointed
(interim)
Osman H. Ahmed
Interim Chief Executive Officer
Rubicon Technologies, Inc.
Effective
2024-06-28
Filed
July 1, 2024, 7:59 PM ET
On June 27, 2024, the Company entered into an Employment Agreement (the “Employment Agreement”) entered into between the Company and Mr. Osman H. Ahmed, wherein the Company offered Mr. Ahmed the position of Interim Chief Executive Officer.
Departed
Phil Rodoni
Chief Executive Officer
Rubicon Technologies, Inc.
Effective
2024-06-28
Successor
Osman H. Ahmed
Filed
July 1, 2024, 7:59 PM ET
On June 27, 2024, Mr. Phil Rodoni and the Company entered into a Separation Agreement (the “Separation Agreement”) wherein Mr. Rodoni resigned from his role as Chief Executive Officer of Rubicon Technologies, Inc. (the “Company”), effective June 28, 2024.
Departed
Ebrahim “Eboo” Versi
Chief Executive Officer
DMK PHARMACEUTICALS Corp
Effective
2024-06-27
Filed
July 1, 2024, 7:59 PM ET
Also effective June 27, 2024, Mr. Versi was separated from his role as Chief Executive Officer of the Company
The Board authorized the Company to extend an offer of employment to Mr. George Scherff to succeed Mr. Knapper as Chief Executive Officer of the Company
On June 27, 2024, Mr. Gene Mack (“Mr. Mack”), the Company’s current Chief Financial Officer, was appointed to serve as Interim Chief Executive Officer (“Interim CEO”), effective as June 25, 2024, to fill the vacancy created by Mr. Alder’s departure as Chief Executive Officer.
On June 25, 2024, Matthias Alder (“Mr. Alder”), Chief Executive Officer of Gain Therapeutics, Inc. (the “Company”), and the Company mutually agreed that his service as Chief Executive Officer of the Company would terminate so that Mr. Alder can pursue other opportunities.
On June 24, 2024, Davinder Singh, the Chief Financial Officer of Tucows Inc. (the “Company”) informed the Board of Directors of the Company (“Board”) of his decision to voluntarily resign from his position to pursue other professional opportunities.
Departed
Chi Wai (Michael) Woo
Chief Executive Officer, Chief Financial Officer, President, Treasurer, Director
Effective June 28, 2024, the Company accepted the resignation of Chi Wai ( Michael) Woo as the CEO, CFO, President, Treasurer, and as a member of the Company’s Board of Directors.
The Board has unanimously appointed Martina L. Cheung, currently the Company's President of S&P Global Ratings, to succeed Mr. Peterson as Chief Executive Officer and President, effective as of November 1, 2024
As of June 27, 2024, Nicole Sandford, the Company’s Chief Executive Officer, has taken over Dr. Hombeck’ s duties on an interim basis until a search for his replacement is completed.
On June 27, 2024, the Compensation Committee (the “Committee”) of Aspira Women’s Health Inc. (the “Company”) determined that a personal civil matter interfered with Dr. Torsten Hombeck’ s ability to continue to serve as the Company’s Chief Financial Officer.
Appointed
Yixuan Yuan
Chief Executive Officer
Chenghe Acquisition I Co.
Effective
2024-06-24
Filed
June 27, 2024, 7:59 PM ET
Yixuan Yuan as CEO of the Company
Appointed
Zhaohai Wang
Chief Financial Officer
Chenghe Acquisition I Co.
Effective
2024-06-24
Filed
June 27, 2024, 7:59 PM ET
Zhaohai Wang as CFO of the Company
Departed
David S. Smith
Vice President, Chief Financial Officer and Treasurer
the Company’s Board of Directors (the “Board”) appointed Aoife Brennan, M.B., Ch.B., as President and Chief Executive Officer of the Company, effective upon the closing of the Acquisition (the “Effective Date”).
Appointed
Yuan Yixuan
Chief Executive Officer
Chenghe Acquisition II Co.
Effective
2024-06-24
Filed
June 27, 2024, 7:59 PM ET
Effective June 24, 2024, the Board, upon recommendation by the Nominating and Corporate Governance Committee of the Board, appointed Yuan Yixuan, age 31, as chief executive officer of the Company and as a member of the Board.
Departed
Anna Zhou
Chief Executive Officer, Company Secretary and Director
Chenghe Acquisition II Co.
Effective
2024-06-21
Successor
Yuan Yixuan
Filed
June 27, 2024, 7:59 PM ET
Effective June 21, 2024, Anna Zhou resigned from her positions as chief executive officer, company secretary and member of the board of directors (the “Board”) of Chenghe Acquisition II Co. (the “Company”).
On June 27, 2024, Todd Dissinger, Chief Financial Officer (principal financial officer) of Natural Grocers by Vitamin Cottage, Inc. (the “Company”) and its wholly owned subsidiary Vitamin Cottage Natural Food Markets, Inc., notified the Company that he intends to retire from the Company effective on or about December 31, 2024.
On June 24, 2024, Ken Plunk, Senior Vice President and Chief Financial Officer of J & J Snack Foods Corp. (the “Company”), notified the Company of his decision to retire from the Company effective December 31, 2024.
On June 26, 2024, Joseph Risico notified the Board of Directors (the “Board”) of the Company of his decision to resign as Co-Chief Executive Officer of the Company and from the Board, effective as of June 26, 2024.
In connection with Mr. Risico’s resignation, the Board appointed Arturo Rodriguez the sole Chief Executive Officer of the Company and the sole principal executive officer.
Appointed
Ryan Robinson
Chief Financial Officer and Treasurer
Tourmaline Bio, Inc.
Effective
2024-06-25
Filed
June 27, 2024, 7:59 PM ET
On June 25, 2024, the Board of Directors of Tourmaline Bio, Inc. (the “Company”) appointed Ryan Robinson to serve as the Company’s Chief Financial Officer and Treasurer, effective as of June 25, 2024
On June 24, 2024, William J. Fehrman was elected Chief Executive Officer and President of American Electric Power Company, Inc. (“AEP” or the “Company”) effective as of August 1, 2024.
Departed
Michael R. Smith
Executive Vice President and Chief Financial Officer
Mr. Smith will step down from his role as Executive Vice President and Chief Financial Officer effective December 1, 2024, and will continue thereafter as Executive Vice President of McCormick to assist with the transition until his retirement from McCormick on February 28, 2025.
Appointed
Marcos Gabriel
Executive Vice President and Chief Financial Officer
On June 25, 2024, the Board of Directors (the “Board”) of McCormick & Company, Incorporated (“McCormick”) appointed Marcos Gabriel as Executive Vice President and Chief Financial Officer of McCormick effective December 1, 2024.
Timothy Brown will step down as interim Chief Financial Officer of HP Inc. (“HP”) effective upon HP’s appointment of a new Chief Financial Officer on August 5, 2024, as disclosed below.
Departed
Winthrop Watson
President and Chief Executive Officer
Federal Home Loan Bank of Pittsburgh
Effective
2024-12-31
Successor
David G. Paulson
Filed
June 26, 2024, 7:59 PM ET
On June 24, 2024, Winthrop Watson, President and Chief Executive Officer (CEO) of the Federal Home Loan Bank of Pittsburgh (Bank), notified the Bank’s Board of Directors (Board) that he intends to retire from the Bank, effective December 31, 2024.
Appointed
David G. Paulson
President and Chief Executive Officer
Federal Home Loan Bank of Pittsburgh
Effective
2024-12-31
Filed
June 26, 2024, 7:59 PM ET
The Board has named David G. Paulson as President and CEO, effective upon Mr. Watson’s retirement.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.